Cargando…
Naringenin promotes angiogenesis of ischemic myocardium after myocardial infarction through miR-223-3p/IGF1R axis
INTRODUCTION: Naringenin exerts a protective effect on myocardial ischemia and reperfusion. It has been reported that miR-223-3p is a potential target for the treatment of myocardial infarction (MI). In view of the unreported correlation between Naringenin and miR-223-3p, this study was designed to...
Autores principales: | Fu, Jinguo, Niu, Heping, Gao, Guangren, Wang, Lei, Yu, Kai, Guo, Run, Zhang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471969/ https://www.ncbi.nlm.nih.gov/pubmed/36161098 http://dx.doi.org/10.1016/j.reth.2022.07.008 |
Ejemplares similares
-
MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
por: Jia, Cheng You, et al.
Publicado: (2011) -
MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction
por: Elbaz, Meyer, et al.
Publicado: (2022) -
Engineered Exosomes With Ischemic Myocardium‐Targeting Peptide for Targeted Therapy in Myocardial Infarction
por: Wang, Xu, et al.
Publicado: (2018) -
ZNF561-AS1 Regulates Cell Proliferation and Apoptosis in Myocardial Infarction Through miR-223-3p/NLRP3 Axis
por: Li, Xiaoyu, et al.
Publicado: (2022) -
MiR-223 or miR-126 predicts resistance to dual antiplatelet therapy in patients with ST-elevation myocardial infarction
por: Li, Xiaojing, et al.
Publicado: (2021)